Bio-Techne (TECH) Q3 2024 Earnings
TECH·Reported May 1, 2024·Before market open
Bio-Techne reported Q3 2024 revenue of $303.4M, missed analyst consensus of $306.1M by $2.6M. Diluted EPS came in at $0.48, beat the $0.45 consensus by $0.03.
Revenue
$303.4Mmissed by $2.6M
Consensus: $306.1MDiluted EPS
$0.48beat by $0.03
Consensus: $0.45
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Bio-Techne's Q3 2024 earnings report.
Bio-Techne (TECH) reported Q3 2024 earnings on May 1, 2024 before market open.
Bio-Techne reported revenue of $303.4M and diluted EPS of $0.48 for Q3 2024.
Revenue missed the consensus estimate of $306.1M by $2.6M. EPS beat the consensus estimate of $0.45 by $0.03.
You can read the 10-Q periodic report (0001558370-24-006803) directly on SEC EDGAR. The filing index links above go to sec.gov.